Rapid Dose Therapeutics Company Description

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada.

The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products.

It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips containing active ingredients.

In addition, the company sells health and wellness products, consisting of nutraceuticals and infused soaps; and white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing, as well as provides licensing and consulting services.

Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.

Rapid Dose Therapeutics Corp.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Mark Upsdell

Contact Details

Address: 1121 Walker's Line Burlington, Ontario L7N 2G4 Canada
Phone	416 477 1052
Website	rapid-dose.com

Stock Details

Ticker Symbol	DOSE
Exchange	Canadian Securities Exchange
Fiscal Year	March - February
Reporting Currency	CAD
ISIN Number	CA75339A1012
SIC Code	8731

Key Executives

Name	Position
Mark Andrew Upsdell	Founder, President, Chief Executive Officer and Director
Douglas Alan Hyland C.A., CPA	Chief Financial Officer
Jason Lewis	Senior Vice President of Business Development and Director
Ben Macphail M.Sc.	Chief Scientist
Donald Alexander-R. Sheldon B.A.Sc., L.L.B., LL.B, M.A.Sc., P.Eng.	Legal Counsel
Rishi Kapadia	Controller
Jorge Estepa	Assistant Corporate Secretary